Timed Bromocriptine-QR Therapy Reduces Progression of Cardiovascular Disease and Dysglycemia in Subjects with Well-Controlled Type 2 Diabetes Mellitus

Figure 2

Kaplan-Meier estimates of the proportion of subjects by treatment that experienced an event within the composite CVD endpoint.